Cardinal Health, Inc. · NYSE:CAH
Cardinal Health — Q3 FY2009 Earnings Presentation
18 slides from Cardinal Health's earnings presentation, Apr 30, 2009
Slide 1: Essential to care Q3FY2009 Investor/Analyst Call
Essential to care Q3FY2009 Investor/Analyst Call Exhibit 99.3 April 30, 2009
Slide 2: Forward-looking statements and GAAP reconciliation
Forward-looking statements and GAAP reconciliation This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual
Slide 3: Agenda
Agenda Opening remarks Kerry Clark Chairman and Chief Executive Officer Financial overview Jeff Henderson Chief Financial Officer HSCS comments George Barrett Vice Chairman and CEO Healthcare Supply Chain Services CMP comments Dave Schlotterbeck Clinical and Medical Products Q&A Vice Chairman and CE
Slide 4: Cardinal Health
CardinalHealth Essential to care™
Slide 5: Q3 FY2009 Financial Review
Q3 FY2009 Financial Review $24,939 $496 $314 $0.87 $821 15.1% ($M) 9% (14%) (14%) (15%) % Change GAAP Basis $24,939 $553 $350 $0.97 16.9% ($M) 9% (10%) (10%) (10%) % Change Non-GAAP Basis % change over prior year quarter Revenue Operating earnings Earnings from continuing ops Diluted EPS from contin
Slide 6: Q3 FY2009 Operating Earnings and EPS
Q3 FY2009 Operating Earnings and EPS Operating Earnings ($M) Diluted EPS from Continuing Operations Operating Earnings ($M) Diluted EPS from Continuing Operations GAAP consolidated $496 $0.87 $577 $1.02 Special items (Note) $52 $0.11 $36 $0.06 Impairments, (gain)/loss on sale of assets and other, ne
Slide 7: Healthcare Supply Chain Services Business Analysis
Healthcare Supply Chain Services Business Analysis Highlights: • Revenue up 9% on growth in pharma supply chain business • Revenue from bulk pharmaceutical customers up 19%, primarily due to increased volumes from existing customers • Revenue from non-bulk pharmaceutical customers up 3%, driven by o
Slide 8: Clinical and Medical Products Business Analysis
Clinical and Medical Products Business Analysis Highlights: • Segment revenue down 6% over prior year due to the previously reported deferral in hospital capital spending and negative impact of foreign exchange (~4 pps), partially offset by the Enturia acquisition • Segment profit down 22% due to th
Slide 9: HSCS Update
HSCS Update • Pharmaceutical – Strong revenue growth – Momentum with DSD customers – Strong nuclear pharmacy quarter • Medical – Solid profit growth – Signs of softness in hospital admissions and physicians visits – Continued focus on efficiency and category management • Disciplined management of op
Slide 10: CMP Update
CMP Update • FY09(E) segment profit down 7-11% – Alaris remediation reserve and ship-hold impact – Continued hospital deferral in capital spending – Reduction in workforce, stringent cost controls to primarily impact FY10 and beyond – Disposables are steady, recurring stream • Progress made towards
Slide 11: Te nates
Te nates Essential to care™
Slide 12: FY 2009 Priorities
FY 2009 Priorities • Investing judiciously to enhance key quality and regulatory systems • Return HSCS to steady growth • Continue to invest (R&D) in CMP growth • Complete integrations (VIASYS ® , Enturia, Borschow) • Prepare organization for and execute spinoff of CareFusion Corporation
Slide 13: Cardinal Health
CardinalHealth Fssential to care™
Slide 14: Cardinal Health
— CardinalHealth Essential to care™
Slide 15: Q3FY09 Trailing Five Quarters
Q3FY09 Trailing Five Quarters
Slide 16: Segment Analysis: Q3FY09
Segment Analysis: Q3FY09 Q3FY08 Q4FY08 Q1FY09 Q2FY09 Q3FY09 Q3FY09/ Q3FY08 % change Revenue ($M) $21,923 $21,863 $23,418 $24,096 $ 23,958 9% Segment Profit ($M) $377 $324 $292 $333 $384 2% Healthcare Supply Chain Services Q3FY08 Q4FY08 Q1FY09 Q2FY09 Q3FY09 Q3FY09/ Q3FY08 % change Revenue ($M) $1,170
Slide 17: Segment Analysis: Q3FY09
Segment Analysis: Q3FY09 Q3FY08 Q4FY08 Q1FY09 Q2FY09 Q3FY09 Q3FY09/ Q3FY08 % change Revenue ($M) $308 $288 $273 $265 $246 (20%) Segment Profit ($M) $27 $27 $24 $31 $23 (12%) All Other Segment
Slide 18: GAAP to Non-GAAP Reconciliation Statements
GAAP to Non-GAAP Reconciliation Statements CARDINAL HEALTH, INC. AND SUBSIDIARIES GAAP / NON-GAAP RECONCILIATION Third Quarter 2009 Year-to-Date 2009 (in millions, except per Common Share amounts) GAAP Special Items Other Spin-Off Costs Impairments, (Gain)/Loss on Sale of Assets and Other, Net Non-G